Bayer Wins Roundup Cancer Trial and Awaits Ruling on $7.25B Settlement
Bayer's Legal Battle Over Roundup Cancer Claims
By Dietrich Knauth
NEW YORK, Oct 29 (Reuters) - Bayer won a trial on Thursday over claims by three women that its Roundup weedkiller caused their cancer, while awaiting a broader ruling from a separate court on the company's $7.25 billion effort to settle other Roundup cases.
Impact of Supreme Court Ruling on Roundup Lawsuits
The trial was a test for the continued viability of Roundup lawsuits after a US Supreme Court ruling in Bayer's favor limited the legal claims that plaintiffs can bring.
It comes as Bayer is separately seeking to resolve tens of thousands of other Roundup lawsuits through a proposed $7.25 billion settlement, which is under review by a Missouri state court judge in St. Louis.
Details of the Recent Trial
A St. Louis jury unanimously ruled for Bayer-owned Monsanto in the first case to go to trial after June's Supreme Court ruling. The litigation has weighed on Bayer since its 2018 acquisition of Monsanto, costing the company billions of dollars and driving down its share price.
Bayer's Response to the Verdict
Bill Dodero, Bayer's US general counsel and global head of litigation, said the verdict showed how difficult it would be for other plaintiffs to win cases after the Supreme Court ruling.
"This verdict should send a strong signal that plaintiffs who wish to pursue claims in the court system following the Durnell ruling will face significant challenges both in demonstrating they have viable claims and putting forth the necessary evidence to prove them in court," Dodero said in a statement.
Plaintiffs' Claims and Legal Arguments
Background of the Plaintiffs
PLAINTIFFS SUED IN 2020
Plaintiffs Theresa Aretino, Cynthia Fernandez and Betty Larkin sued Bayer unit Monsanto in 2020 in St. Louis, saying they used Roundup regularly and later developed non-Hodgkin lymphoma. Their attorneys argued that Roundup was defectively designed and unreasonably dangerous, and that Bayer was negligent in selling it.
The three women are not participating in Bayer's proposed settlement. Fernandez died before the trial began.
Reuters viewed the trial and verdict on Courtroom View Network. Attorneys for Aretino, Fernandez and Larkin did not immediately respond to a request for comment late on Thursday.
Bayer's Defense and Scientific Evidence
Bayer has denied the claims and said that decades of studies have shown glyphosate, Roundup's active ingredient, is safe and does not cause cancer.
Bayer faces around 65,000 claims in US state and federal courts from plaintiffs who say they developed cancer after using Roundup at home or on the job.
Regulatory and Scientific Perspectives
Before the Supreme Court ruling this year, most lawsuits had alleged that Roundup’s label failed to warn consumers about cancer risks. But the court blocked those legal arguments in June, ruling that federal law requires herbicide makers to use the exact label approved by the US Environmental Protection Agency. The EPA has concluded that Roundup’s label does not require a cancer warning.
Bayer has argued that other legal claims, including design-defect and negligence, are also foreclosed by the US Supreme Court's ruling, but plaintiffs' attorneys have argued that those claims are not affected by the ruling.
The EPA has previously concluded that glyphosate is probably not carcinogenic, but it is in the middle of a new review of its safety.
In 2015, the International Agency for Research on Cancer concluded that glyphosate was “probably carcinogenic” to humans, but Bayer has said that is an outlier opinion based on flawed methodology.
(Reporting by Dietrich Knauth; Editing by Alexia Garamfalvi, Jonathan Spicer and Jamie Freed)
